University of Ioannina
Επιδημιολογική, κλινική, γενετική μελέτη ασθενών με φλεγμονώδη πάθηση των εντέρων και λειτουργική ανίχνευση ενδοκυττάριων μηχανισμών της νόσου σε πειραματικά πρότυπα
Abstract
dc:descriptionThe chronic inflammatory bowel diseases (IBD), Crohn’s disease and Ulcerative colitis are common causes of gastrointestinal morbidity in the developed countries. Recent population based studies suggest that combined prevalence of these diseases approaches 400 per 100.000. CD (Crohn’s disease) is characterized by transmural patchy granulomas inflammation of any part of the gastrointestinal tract, although it is most common in the ileocecal area. UC (Ulcerative colitis), in contrast to CD, is limited to the colon, involves mainly the superficial layers of the bowel (mucosa) is continuous and not associated with granulomas. Despite extensive research over several decades, the aetiologic agents and the events initiating and sustaining chronic inflammatory responses in the bowel, remain largely unknown. The current most comprehensive hypothesis for IBD is that it presents a heterogeneous group of diseases that have a common final manifestation, which is mucosal inflammation, and that several genetic and environmental factors are implicated in the pathogenesis of the disease. The important role of genetic factors in the cause and the heterogeneity of IBD are strongly supported genetic epidemiologic studies, including consistent ethnic differences, familial aggregation, and increased concordance rate in monozygotic twins. In particular, the two regions of linkage initially described in 1996 on chromosomes 16 and 12 have been subjected to rigorous reanalysis throughout the world. Genome wide searches have identified susceptibility loci on chromosomes 1, 3, 5, 7, 6, 12, 14, 16 and 19. Three independent groups reported associations between the NOD2/CARD15 gene located on chromosome 16 in IBD 1 locus and susceptibility to Crohn’s disease. Two missense and one frameshift which leads to a truncation of the protein in the leucine rich repeat region were significantly associated with Crohn’s disease. Bacterial LPS binds to a leucine-rich repeat region in the NOD2/CARD15 protein leading to activation of NF-kb but this induction is deficient in mutant NOD2, suggesting a link between an innate immune response to bacterial components and development of disease. A number of other regions have been implicated in many genome searches which have now been reported throughout the world. Thus, despite this considerable progress, current data are not sufficient enough to allow gene testing for inflammatory bowel disease and translation from basic research to clinical application. In the absence of pathognomic markers for CD and UC, the diagnosis of IBD depends on a combination of clinical, radiographic, endoscopic and histological criteria. However, notwithstanding the application of several classification systems differentiation between CD and UC in approximately 10% of cases of colitis can not be made. Furthermore, even when a differential diagnosis is possible, the age at onset, the extent of the disease, extraintestinal manifestations, the natural course of the disease and the response to treatments may be defined several clinical subgroups of patients. These phenotypic variations suggest several underlying genetic backgrounds and/or several aetiologic factors for IBD. The major goals of this PhD are to foster the interaction of fundamental and clinical research around the diagnosis, genetics and aetiology of IBD.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Filis, Grigorios
- Φίλης, Γρηγόριος
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18032